Merck & Co., Inc.
Close on Nov 2, 2026Market cap $366.03BP/E 118.7Yield 2.21%
Merck Gardasil / Gardasil 9 — China sales by Quarter
Gardasil / Gardasil 9 — China sales ($M) ($M)
Merck Gardasil / Gardasil 9 — China sales: $0M in Q4 2025, down 100.0% from a year earlier. That is the lowest of the 8 quarters on record here.
Where the Q4 2025 figure comes from
“$193 million, $0, $0 and $0 in the first, second, third and fourth quarter of 2025”
Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Reported in Form 8-K Table 3c / 3b Footnote (Gardasil/Gardasil 9 sales in China).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Gardasil / Gardasil 9 — China sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q4 2025 | Dec 31, 2025 | 0 | -100.0% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q3 2025 | Sep 30, 2025 | 0 | -100.0% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q2 2025 | Jun 30, 2025 | 0 | -100.0% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q1 2025 | Mar 31, 2025 | 193 | -84.6% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q4 2024 | Dec 31, 2024 | 446 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q3 2024 | Sep 30, 2024 | 517 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q2 2024 | Jun 30, 2024 | 1,312 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| Q1 2024 | Mar 31, 2024 | 1,253 | – | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
Cite this data
StockData. (2026). Merck Gardasil / Gardasil 9 — China sales ($M), quarterly Q1 2024–Q4 2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-gardasil-china
See every metric in the Merck KPI table. Data updated Oct 26, 2026.